Purification and Biochemical character of hPL were already described (Folia Endocri. Japon., 49,882 and 49, 1059, 1973).
In this paper, the author describes the immunological character of hPL and the method of the immunological measurement using its antigenecity. Anti-hPL serum was prepared by injecting purified hPL-Kobe with complete Freund's adjuvant into the male guinea pig or male rabbit, and had the specific titer to show cross reaction with 25 μg/ml hPL on Ouchterlony, but no cross reaction with human serum.
1. Immunological Character of HPL-Kobe
As reported, the biological action of hPL includes somatotropic or metabolic action (Sciarra et al., 1963, Tojo et al., 1972, Tanaka, 1972) and lactogenic or luteotrophic action (Ito & Higashi, 1961, Josimovich et al., 1962). So the cross-reactivity of antihPL serum was investigated on Ouchterlony immunodiffusion against the human pituitary proteohormones, such as human growth hormone (hGH) and human prolactin (hPRL), or the human chorionic such as human chorionic gonadotropin (hCG) and human chronic thyrotropin (hCT).
HPRL, hCG and hCT did not show the precipitation line against anti-hPL serum and a single line was observed against hGH which showed only a partial identity for hPL. On immunoelectrophoresis using anti-hGH serum, hGH and hPL showed a single precipitation line in agar gel and hGH migrate more rapidly to the cathode. These results reveal that hPL shares antigenic determinants not present in the other.
2. Immunoassay o f HPL
For the estimation of human placental lactogen (hPL) three different immunoassay procedures, such as radioimmunoassay (RIA), single radial immunodiffusion (SRI) and hemagglutination inhibition reaction (HAIR) are reported here.
(1) HPL-Double Antibody Radioimmunoassay (HPL-RIA)
HPL-Kobe was used as the standard sample or the sample for iodination, and antisera to hPL was prepared in guinea pig against a purified hPL-Kobe. The iodination step presently used followed after the procedure described for growth hormone (Greenwood et al., 1963) with very minor modification. The reaction time of chloramin T was 15 sec.. The dilution of anti-hPL serum was 1 : 10000, first incubation time was 48 hrs.. and second incubation time was 24 hrs.. The standard curve obtained was sensitive, and unlabelled hPL over 0.006 μg/ml was measurable. Using this method, serum hPL of the normal pregnant woman was measured, which revealed that hPL was detectable on the 8th week of gestation. The concentration was 0.03-0.01/μg/ml. Thereafter, it rapidly increased to reach a peak of 4-10, μg/ml at term. A small amount of hPL was detectable in the cord blood and urine of the pregnant woman. Serum hPL was very low or undetectable in the abnormal pregnancy with hypofunction or dysfunction of placenta such as threatened abortion which terminated in abortion, ectopic pregnancy, fetal death in utero and hydatidiform mole. These facts indicate that measurement of serum hPL in the pregnant woman by hPL-RIA is one of the helpful ways to judge pla-cental function.
(2) HPL-Single Radial Immunodiffusion (HPL-SRI)
The principle of SRI reported by Mancini et al. (1965) was applied to the measurement of hPL. The conditions of method were determined by easiness to read the precipitation ring and the area of the ring : anti-serum concentration in the agar plate, 1.0% : thickness of the plate, 1.2 mm. : the diameter of the well, 4 mm. HPL-Kobe as a standard sample was diluted at stepwise concentration and placed in the well. Three days later, the diameter of each precipitation ring formed a line with 5.48 of regression coefficient and the sensitivity was 5μg/ml. When serum hPL of normal pregnant women was measured simultaneously by hPL-SRI and hPL-RIA, the values measured by hPL SRI were 2-3 times higher than those by hPL-RIA. But normal ranges by both methods increased with identical pattern.
View full abstract